Home/Pipeline/ECO Synthesis Platform Partnership

ECO Synthesis Platform Partnership

Cardiovascular Indication

PreclinicalActive

Key Facts

Indication
Cardiovascular Indication
Phase
Preclinical
Status
Active
Company

About Codexis

Codexis is a mission-driven biotech company that engineers custom enzymes to enable more efficient, sustainable, and scalable manufacturing of pharmaceuticals and RNA therapeutics. Its core achievements include powering the synthesis of blockbuster drugs like sitagliptin (Januvia®), rapidly scaling an enzyme for Pfizer's Paxlovid, and launching a next-generation enzymatic RNA manufacturing platform. The company's strategy is partner-centric, focusing on providing its proprietary CodeEvolver® and ECO Synthesis® platforms as enabling technologies to biopharma companies, thereby de-risking and accelerating their development pipelines without developing its own drug assets.

View full company profile